Our editorial team compared every key metric — fees, rules, profit split, payouts — so you can pick the right firm.
| Feature | DNA Funded | iFunds |
|---|---|---|
| Payout | ||
| Profit Split | 80% (up to 90%) | 50-80% (inversely linked to max DD chosen) |
| First Payout | 14 | On demand |
| Payout Frequency | From day 14 (day 7 with add-on) | On demand |
| Max Account Size | $200,000 | $500,000 |
In this independent head-to-head comparison of DNA Funded vs iFunds, we break down challenge rules, pricing, profit splits, and payout conditions to help you decide which prop firm is the better fit for your trading style.
DNA Funded: 10-Day Rapid Challenge. 24-Hour Entry from $25. $600K Scaling.
iFunds: No Evaluation. Choose Your Own Max DD. 50-80% Split. 24h Payout Guarantee.
Based on our independent scoring methodology, DNA Funded scores 7.9/10 overall — but the best choice depends on your specific needs. Read the full comparison below.
BestProp Score: DNA Funded scores 7.9/10 vs iFunds at 7.8/10.
Minimum Fee: DNA Funded starts from $25; iFunds starts from $250. DNA Funded is cheaper at entry level.
Profit Split: DNA Funded offers 80% (up to 90%); iFunds offers 50-80% (inversely linked to max DD chosen). DNA Funded has the higher split.
Platforms: DNA Funded supports TradeLocker; iFunds is on MT4, MT5.
Tradeable Markets: DNA Funded covers Forex, Indices, Commodities, Stocks, Crypto; iFunds offers Forex, Metals, Energies, Crypto, Stocks.
Challenge fees are typically the biggest factor when choosing a prop firm. Here is how DNA Funded and iFunds compare on pricing.
DNA Funded challenge fees start from $25.
iFunds challenge fees start from $250. The firm has operated since 2024.
On entry-level pricing, DNA Funded offers a lower starting fee — an important factor if you are testing with a smaller account first.
DNA Funded profit split: 80% (up to 90%). iFunds profit split: 50-80% (inversely linked to max DD chosen). DNA Funded delivers the higher cut to traders.
Payout frequency: DNA Funded pays From day 14 (day 7 with add-on); iFunds pays On demand. Faster payouts are better for cash flow management.
Here is our full independent review of DNA Funded:
DNA Funded is led by CEO Martin Doepke and registered in Saint Lucia. The firm offers five distinct challenge types including a genuinely unusual 10-day Rapid Challenge and a 24-hour micro-challenge entry point from just $25. Maximum scaling reaches $600,000. Trading is conducted exclusively on TradeLocker.
One important cost factor to understand before joining: DNA Funded charges a flat $5 commission per non-crypto trade and a 0.1% fee on crypto trades. This is separate from the challenge fee and applies on funded accounts. For high-frequency traders executing many positions per day, this commission structure adds meaningful ongoing cost that should be factored into profitability calculations before choosing this platform.
DNA Funded suits traders who want a wide range of challenge formats – from a $25 24-hour entry challenge all the way to a $200K two-phase evaluation. The Rapid Challenge is the most distinctive offering: a strict 10-calendar-day window with a 5% profit target, designed for traders who want fast confirmation of their edge without an open-ended evaluation period.
USA and Canadian traders are excluded. Grid and martingale strategies are prohibited. News trading is allowed but restricted to a 5-minute window before and after major releases.
Single platform: TradeLocker. Instruments: forex, indices, commodities, stocks, cryptocurrencies (all CFDs). Restricted countries: USA, Canada, Iran, North Korea, Syria, Sudan, Cuba, Crimea region.
DNA Funded earns a 6.7 BestProp score. The 10-day Rapid Challenge and $25 24-hour entry challenge are genuinely unique formats not available at most competitors. The programme variety (5 types) is solid and the 5% Rapid target is accessible.
The per-trade $5 commission is the most significant negative in the platform – it adds cost that compounds quickly for active traders and is not present at most competing firms. The Trustpilot score of 3.8/5 from 72 reviews is a small sample but moderate. The 5% cap on the first 3 payouts, $50 bank transfer fee, and single-platform limitation (TradeLocker only) further constrain the value proposition. DNA Funded is worth considering specifically for the Rapid Challenge format – for general prop trading the commission structure warrants careful analysis before committing.
Here is our full independent review of iFunds:
iFunds is operated by iFunds Ltd (Saint Lucia, Registration No. 2024-00154) and Synerjic Ltd (Cyprus, Registration No. 474148), led by CEO Layth Sanjaq. The firm offers a purely instant-funded model — there is no evaluation phase. Traders receive capital immediately and configure their own risk parameters at purchase. iFunds holds a 4.7/5 Trustpilot rating with 93% five-star reviews. Maximum account size is $500,000. Payouts are processed within 24 hours, with a 10% bonus (up to $1,000) if the 24-hour window is missed.
The defining feature of iFunds is its customizable risk-reward model: traders select their maximum drawdown threshold at account purchase (between 6% and 10% of initial balance). A lower chosen drawdown ceiling yields a higher profit split; a higher drawdown tolerance yields a lower split. This places risk management directly in the trader’s hands from day one.
No evaluation. No profit target to begin trading. Traders select a max drawdown level — the lower the max DD they accept, the higher their profit share. The exact split-to-DD mapping is:
There is no daily loss limit on any iFunds account — only the chosen maximum drawdown applies. This gives traders full intraday flexibility; only the total equity drop from the starting balance is monitored.
Note: fees represent a meaningful percentage of account size on smaller accounts ($250 for $2,500 = 10%). This is consistent with instant-funded models where no evaluation filters risk, and reflects the immediacy of funded access. Fees are described as a participation fee — refund terms are governed by iFunds’ separate Refund Policy.
Platforms: MetaTrader 4, MetaTrader 5. Instruments: Stocks, currencies, metals, energies, cryptocurrencies. Leverage: up to 1:100 (dynamic, based on risk level). All instruments accessible on both platforms with the same account.
iFunds earns a 6.5 BestProp score. The customizable risk-reward model is genuinely innovative — letting traders choose their own drawdown tolerance and receive a commensurate profit share puts risk management in the right hands. 4.7/5 Trustpilot with 93% five-star reviews is excellent for a 2024-registered firm. No daily loss limit provides real intraday freedom. EAs, news trading, trade copiers, and multi-IP are all permitted with minimal restrictions. On-demand payouts with a 24-hour guarantee and bonus incentive are strong operational commitments.
The main caution is the fee-to-account-size ratio on small accounts: $250 for a $2,500 funded account is a 10% upfront cost, and the base profit split at the highest drawdown tolerance is only 50%. Traders who want immediate funding of small accounts should run the numbers carefully — at 50% split and $250 fee, the break-even is $500 in gross profit (1 * fee * 2), meaning the account must gain 20% before the trader recups the fee net of split. iFunds works best for confident, disciplined traders who can accept tight drawdown limits in exchange for a higher profit share, or those with access to automated strategies that benefit from no daily DD restriction. The 2024 registration means the track record, while so far positive, is less than two years old.
Overall, our independent scoring gives DNA Funded the edge in this 2026 comparison. However, both firms have their merits. If iFunds better matches your specific trading style, instruments, or preferred platform, it may still be the right choice for you.
Use our comparison table above and review the challenge fees at both firms before making your final decision. Both offer risk-free evaluation programs — the challenge fee is the only money at risk.
Based on our independent scoring, DNA Funded scores higher overall (7.9/10). The best choice depends on your trading style, preferred instruments, and account size.
DNA Funded offers a lower entry-level challenge fee. However, always compare the full account sizes you plan to trade before deciding purely on price.
DNA Funded offers the higher profit split. DNA Funded: 80% (up to 90%). iFunds: 50-80% (inversely linked to max DD chosen).
EA policies: DNA Funded — check the review. iFunds — check the review. Always verify the latest policy directly with the firm.
News trading: DNA Funded — check the review. iFunds — check the review.
Read the full DNA Funded review → · Read the full iFunds review →
Based on our scoring methodology, DNA Funded edges ahead in this comparison. However, the best choice depends on your trading style, preferred platform and account size. Read the full breakdown above for a detailed verdict.
DNA Funded offers 80% (up to 90%) profit split, while iFunds offers 50-80% (inversely linked to max DD chosen) profit split. Check each firm's current terms as these can change.
Check our offers page for the latest verified deals on both firms.
DNA Funded processes first payouts in 14 day(s), while iFunds takes approximately On demand day(s). Always verify current payout timelines on the firm's website.
Neither DNA Funded nor iFunds are regulated in the traditional financial sense — prop firms operate as private companies providing traders access to simulated or real capital. Always read the terms and conditions carefully before participating in any prop challenge.
